A clinic blueprint for post-coronavirus disease 2019 RECOVERY: learning from the past, looking to the future

DD Lutchmansingh, MP Knauert, DE Antin-Ozerkis… - Chest, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 pandemic poses extraordinary
challenges. The tremendous number of coronavirus disease 2019 (COVID-19) cases in the …

Long-term treatment of venous thromboembolism

C Kearon, SR Kahn - Blood, The Journal of the American …, 2020 - ashpublications.org
The most important decision in the long-term treatment of venous thromboembolism (VTE) is
how long to anticoagulate. VTE provoked by a reversible risk factor, or a first unprovoked …

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry

S Guth, AM D'Armini, M Delcroix… - ERJ open …, 2021 - Eur Respiratory Soc
Background Pulmonary endarterectomy (PEA), pulmonary arterial hypertension (PAH)
therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for …

Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary …

XD Manz, R Szulcek, X Pan, P Symersky… - American journal of …, 2022 - atsjournals.org
Rationale: von Willebrand factor (vWF) mediates platelet adhesion during thrombosis. While
chronic thromboembolic pulmonary hypertension (CTEPH) is associated with increased …

Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

E Mahmud, M Patel, L Ang, D Poch - Pulmonary Circulation, 2021 - journals.sagepub.com
Balloon pulmonary angioplasty (BPA) is an emerging treatment option for patients with
chronic thromboembolic pulmonary hypertension (CTEPH) who have inoperable …

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020

MM Madani - Pulmonary circulation, 2021 - journals.sagepub.com
Pulmonary endarterectomy is the treatment of choice for patients with operable chronic
thromboembolic pulmonary hypertension (CTEPH) as it is potentially curative. In expert …

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary …

Q Jin, Q Luo, T Yang, Q Zeng, X Yu, L Yan, Y Zhang… - Respiratory …, 2019 - Springer
Background Balloon pulmonary angioplasty (BPA) has been demonstrated to improve
cardiac function and exercise capacity in patients with inoperable chronic thromboembolic …

A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension

MJ Colebank, MU Qureshi… - American Journal …, 2021 - journals.physiology.org
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by recurrent or
unresolved pulmonary thromboemboli, leading to perfusion defects and increased arterial …

[HTML][HTML] Clinical–radiological–pathological correlation in chronic thromboembolic pulmonary hypertension

T Verbelen, L Godinas, P Dorfmüller… - European …, 2023 - Eur Respiratory Soc
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially life-
threatening complication of acute pulmonary embolism. It is characterised by persistent fibro …

Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease with and without Pulmonary Hypertension: A …

V Aggarwal, J Giri, SH Visovatti, E Mahmud… - Circulation, 2024 - Am Heart Assoc
Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients
with chronic thromboembolic pulmonary disease with and without pulmonary hypertension …